Results 21 to 30 of about 762,477 (313)

Klebsiella pneumoniae pneumonia

Heart & Lung, 1997
Klebsiella pneumoniae is an uncommon cause of community-acquired pneumonia except in alcoholics. Klebsiella may mimic pulmonary reactivation tuberculosis because it presents with hemoptysis and cavitating lesions. Klebsiella pneumoniae is a difficult infection to treat because of the organism's thick capsule.
S E, Prince, K A, Dominger, B A, Cunha, N C, Klein   +3 more
openaire   +2 more sources

Tuberculosis in migrants – screening, surveillance and ethics

Pneumonia, 2020
Tuberculosis (TB) is the leading infectious cause of human mortality and is responsible for nearly 2 million deaths every year. It is often regarded as a ‘silent killer’ because it predominantly affects the poor and marginalized, and disease outbreaks ...
Gabriella Scandurra, Chris Degeling, Paul Douglas, Claudia C. Dobler, Ben Marais   +4 more
doaj   +1 more source

The History of Mycoplasma pneumoniae Pneumonia [PDF]

Frontiers in Microbiology, 2016
In the United States in the 1930s, although the pathogen was not known, atypical pneumonia was clinically distinguished from pneumococcal pneumonia by its resistance to sulfonamides. Reimann (1938) reported seven patients with an unusual form of tracheo bronchopneumonia and severe constitutional symptoms.
openaire   +3 more sources

Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy [PDF]

, 2001
Background: Patients with human immunodeficiency virus (HIV) infection and a history of Pneumocystis carinii pneumonia are at high risk for relapse if they are not given secondary prophylaxis. Whether secondary prophylaxis against P.
H. Furrer, Uberti-Foppa, C., Pradier, C., Bickel, M, Monforte, A D´Arminio, Bickel, M., M. M. E. Schneider, Uberti-Foppa, C, O. Kirk, Furrer, H, Kirk, O., Schneider, M. M., Kirk, O, Lundgren, Jens Dilling, Ledergerber, B., Mocroft, A., Ledergerber, B, Lundgren, J.D., M. Bickel, P. Reiss, Lundgren, J. D., d'Arminio Monforte, A., Pradier, C, A. d'Arminio Monforte, Lederberger, B., Furrer, H., Reiss, P, Schneider, MM, A. Mocroft, for eight European HIV Cohorts, B. Ledergerber, C. Pradier, J. D. Lundgren, Schneider, M.M.E., Mocroft, A, Reiss, P., C. Uberti Foppa   +36 more
core   +1 more source

Treatment of community-onset pneumonia in neutropenic cancer patients: β-lactam monotherapy versus combination antibiotic regimens

Pneumonia, 2019
Background Although β-lactam monotherapy may be sufficient in non-critically ill patients with community-acquired pneumonia, the value of combination antibiotic regimens in community-onset neutropenic pneumonia remains unclear.
Hyeri Seok, Jae-Hoon Ko, Kyong Ran Peck, Ji-Yeon Kim, Ji Hye Lee, Ga Eun Park, Sun Young Cho, Cheol-In Kang, Nam Yong Lee, Doo Ryeon Chung   +9 more
doaj   +1 more source

Acute respiratory infection as a cause of non-malarial febrile illness in African children.

Pneumonia, 2015
The replacement of “presumptive treatment for malaria” by “test before treat” strategies for the management of febrile illness is raising awareness of the importance of knowing more about the causes of illness in children who are suspected to have ...
Florida Muro, Rita Reyburn, Hugh Reyburn
doaj   +1 more source

Streptococcus pneumoniae outbreaks and implications for transmission and control: a systematic review

Pneumonia, 2018
Background Streptococcus pneumoniae is capable of causing multiple infectious syndromes and occasionally causes outbreaks. The objective of this review is to update prior outbreak reviews, identify control measures, and comment on transmission.
Paul N. Zivich, John D. Grabenstein, Sylvia I. Becker-Dreps, David J. Weber   +3 more
doaj   +1 more source

Inter-hospital variation in the utilization of diagnostics and their proportionality in the management of adult community-acquired pneumonia

Pneumonia, 2018
Background Utilization of diagnostics and biomarkers are the second largest cost drivers in the management of patients hospitalized with community-acquired pneumonia (CAP).
Stefan M. T. Vestjens, Esther Wittermans, Simone M. C. Spoorenberg, Jan C. Grutters, Charlotte A. van Ruitenbeek, G. Paul Voorn, Willem Jan W. Bos, Ewoudt M. W. van de Garde   +7 more
doaj   +1 more source

Effect of prophylactic administration of antipyretics on the immune response to pneumococcal conjugate vaccines in children: a systematic review

Pneumonia, 2021
Background Prophylactic administration of antipyretics at the time of immunization seems to decrease some side effects, however reduced immune responses have been reported in some studies.
Eleni Koufoglou, Georgia Kourlaba, Athanasios Michos   +2 more
doaj   +1 more source

Encouraging rational antibiotic use in childhood pneumonia: a focus on Vietnam and the Western Pacific Region

Pneumonia, 2017
Globally, pneumonia is considered to be the biggest killer of infants and young children (aged
Nguyen T. K. Phuong, Tran T. Hoang, Pham H. Van, Lolyta Tu, Stephen M. Graham, Ben J. Marais   +5 more
doaj   +1 more source